ORBIMED CAPITAL LLC - Insider Non-Derivative Transactions at ARS Pharmaceuticals, Inc. (SPRY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 26, 2024, ORBIMED CAPITAL LLC's relationship to ARS Pharmaceuticals, Inc. (SPRY) is Director, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRY insiders.
Data Source: SEC.
ORBIMED CAPITAL LLC - Insider Non-Derivative Transactions of SPRY Common Stock
ORBIMED CAPITAL LLC - Insider Non-Derivative Transactions at SPRY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 27, 2024 | Sell -- (Common Stock) | 83695 | 13 | 0 |
| Aug 24, 2024 | Sell -- (Common Stock) | 69500 | 13.03 | 83695 |
| Aug 23, 2024 | Sell -- (Common Stock) | 391482 | 12.94 | 153195 |
| Aug 22, 2024 | Sell -- (Common Stock) | 13300 | 14.61 | 544677 |
| Aug 22, 2024 | Sell -- (Common Stock) | 394400 | 13.52 | 557977 |